These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 6408412)

  • 1. Partial or total protection from long-acting monoamine oxidase inhibitors (MAOIs) by new short-acting MAOIs of type A MD780515 and type B MD780236.
    Benedetti MS; Dostert P; Guffroy C; Tipton KF
    Mod Probl Pharmacopsychiatry; 1983; 19():82-104. PubMed ID: 6408412
    [No Abstract]   [Full Text] [Related]  

  • 2. Antagonism between long acting monoamine oxidase inhibitors (MAOI) and MD780515, a new specific and reversible MAOI.
    Kan JP; Benedetti MS
    Life Sci; 1980 Jun; 26(25):2165-71. PubMed ID: 7401915
    [No Abstract]   [Full Text] [Related]  

  • 3. Monoamine oxidase inhibitors and histamine metabolism.
    Benedetti MS; Ancher JF; Sontag N
    Experientia; 1980 Jul; 36(7):818-10. PubMed ID: 6772465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SR 95191, a selective inhibitor of type A monoamine oxidase with dopaminergic properties. II. Biochemical characterization of monoamine oxidase inhibition.
    Kan JP; Steinberg R; Mouget-Goniot C; Worms P; Bizière K
    J Pharmacol Exp Ther; 1987 Jan; 240(1):251-8. PubMed ID: 3100771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics of the inhibition of rat brain monoamine oxidase in vitro by MD780515.
    Kan JP; Strolin Benedetti M
    J Neurochem; 1981 Apr; 36(4):1561-71. PubMed ID: 7264651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The metabolism of dopamine by both forms of monoamine oxidase in the rat brain and its inhibition by cimoxatone.
    Fowler CJ; Benedetti MS
    J Neurochem; 1983 Jun; 40(6):1534-41. PubMed ID: 6406646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cimoxatone is a reversible tight-binding inhibitor of the A form of rat brain monoamine oxidase.
    Fowler CJ; Strolin Benedetti M
    J Neurochem; 1983 Feb; 40(2):510-3. PubMed ID: 6822834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolism of the monoamine oxidase-B inhibitor, MD 780236 and its enantiomers by the A and B forms of the enzyme in the rat.
    Strolin Benedetti M; Dow J; Boucher T; Dostert P
    J Pharm Pharmacol; 1983 Dec; 35(12):837-40. PubMed ID: 6141254
    [No Abstract]   [Full Text] [Related]  

  • 9. Enhancement of 5-HT-induced anorexia: a test of the reversibility of monoamine oxidase inhibitors.
    Fletcher PJ; Yu PH
    Psychopharmacology (Berl); 1989; 98(2):265-8. PubMed ID: 2502797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cumulative effects of irreversible MAO inhibitors in vivo.
    Felner AE; Waldmeier PC
    Biochem Pharmacol; 1979 Apr; 28(7):995-1002. PubMed ID: 444293
    [No Abstract]   [Full Text] [Related]  

  • 11. GABA-elevating effects of the antidepressant/antipanic drug phenelzine in brain: effects of pretreatment with tranylcypromine, (-)-deprenyl and clorgyline.
    Todd KG; Baker GB
    J Affect Disord; 1995 Dec; 35(3):125-9. PubMed ID: 8749840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoamine oxidase in pancreatic islets, exocrine pancreas, and liver from rats. Characterization with clorgyline, deprenyl, pargyline, tranylcypromine, and amezinium.
    Lenzen S; Nahrstedt H; Panten U
    Naunyn Schmiedebergs Arch Pharmacol; 1983 Nov; 324(3):190-5. PubMed ID: 6419132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of monoamine oxidase in monoaminergic neurones in the rat brain by irreversible inhibitors.
    Fagervall I; Ross SB
    Biochem Pharmacol; 1986 Apr; 35(8):1381-7. PubMed ID: 2870717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A monoamine oxidase-B inhibitor, MD 780236, metabolized essentially by the A form of the enzyme in the rat.
    Strolin Benedetti M; Dow J
    J Pharm Pharmacol; 1983 Apr; 35(4):238-45. PubMed ID: 6133934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Limited potentiation of blood pressure response to oral tyramine by brain-selective monoamine oxidase A-B inhibitor, TV-3326 in conscious rabbits.
    Weinstock M; Gorodetsky E; Wang RH; Gross A; Weinreb O; Youdim MB
    Neuropharmacology; 2002 Nov; 43(6):999-1005. PubMed ID: 12423669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MD 240928 and harmaline: opposite selectivity in antagonism of the inactivation of types A and B monoamine oxidase by pargyline in mice.
    Fuller RW; Wong CJ; Hemrick-Luecke SK
    Life Sci; 1986 Feb; 38(5):409-12. PubMed ID: 3945167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intestinal metabolism of tyramine by both forms of monoamine oxidase in the rat.
    Benedetti MS; Boucher T; Carlsson A; Fowler CJ
    Biochem Pharmacol; 1983 Jan; 32(1):47-52. PubMed ID: 6830619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different stereoselective inhibition of monoamine oxidase-B by the R- and S-enantiomers of MD 780236.
    Dostert P; Strolin Benedetti M; Guffroy C
    J Pharm Pharmacol; 1983 Mar; 35(3):161-5. PubMed ID: 6132973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of monoamine oxidase inhibitors on some arylalkylamines in rate striatum.
    Philips SR; Boulton AA
    J Neurochem; 1979 Jul; 33(1):159-67. PubMed ID: 572413
    [No Abstract]   [Full Text] [Related]  

  • 20. Inhibition of semicarbazide-sensitive amine oxidase by monoamine oxidase B inhibitors from the oxazolidinone series.
    Dostert P; Guffroy C; Strolin Benedetti M; Boucher T
    J Pharm Pharmacol; 1984 Nov; 36(11):782-5. PubMed ID: 6150988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.